The last month has been tough going for the consumer genomics industry with frontrunners 23andMe and Ancestory.com both announcing massive layoffs. However, new kid on the block Nebula Genomics is launching a consumer product today that will offer users whole genome sequencing for $299.
“We hope to really revitalize the whole space by making whole genome sequencing affordable, providing more...
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.
Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
Less than a year after the blockchain-enabled genome sequencing startup's launch, Nebula Genomics is announcing its first pharma partnership with Merck KGaA’s EMD Serono. This early partnership will come in the form of a pilot program.
As part of the deal, EMD Serono will be able to use Nebula’s network of anonymized genomic data. This new pilot is specifically zeroing in on lung cancer patients...
We are living in a time when there is increasingly more data being collected, opening up more opportunities for researchers. As the industry begins to see patients become consumers, the conversation around this data has begun to include questions of ownership and compensation.
“What we really want to do is empower patients to take back full control of their data,” Nicolas Schmidt, chief product...
According to IDC, 20 percent of healthcare organizations will be using blockchain by 2020. So should startups in the healthcare space be using it now? Well, not necessarily. While many digital health startups are putting blockchain to good use, for others it might be premature, or even extraneous.
“I think companies over the last couple years have been asking the question ‘I want to use...
It’s hard to have a conversation about technology innovations in 2018 without stumbling into the realm of blockchain. Since it first appeared on most people’s radars — thanks to the ever-turbulent bitcoin and other cryptocurrencies — financial organizations, major retailers and even governments have investigated whether or not the trendy technology has something to offer.
As such, it’s little...
Tattoo circuits. Researchers from Carnegie Mellon University and the University of Coimbra have unveiled a method of printing thin circuits that could better enable wearable computation. The low-cost alloy is attached to a stretchable tattoo paper that adheres to the skin when wet, similarly to the decorative tattoos worn by children.
"This is a breakthrough in the printed electronics area,"...
Data privacy has long been a concern in healthcare, but the past year has seen consumers increasingly concerned about whether or not their devices are always listening. Speaking onstage at Health 2.0's Fall Conference this week in Santa Clara, California with Health 2.0 cofounder and EVP Indu Subaiya, Ricardo Prada, principal UX researcher at Google, said that his company is well aware of the...
Since its founding a little over a year ago, Nebula Genomics has caught the public’s attention for its business model of sequencing consumers' genomes and then letting them trade that data for cryptocurrency. Yesterday the Boston, Massachusetts-based company announced that it landed $4.3 million in seed funding and that it would be partnering with Veritas Genetics, a genome sequencing company. ...
DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers. Recently a smattering of companies have been working to create a market for people to share and sell their personal data to researchers and healthcare players. Those efforts are going one step further, as two growing names in the health data and blockchain industry are...
